June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

pathtalk.org has undergone a recent revision in concept and design from its inception in 2007. Posts from this blog as well as other content from myself and 11 others currently will contribute to the blog.  The administrator for the...

A recent post on "gastric man" was particularly popular.  Here is another one from my own collection.  Several years ago a group at Northwestern published an image of a "lost dog" in the Archives of Pathology...

A story entitled "Recession Now Hits Jobs in Health Care" was in the Wall Street Journal recently. Other stories in the news have discussed closing hospitals, including the possibilty of Shriners hospitals closing.  My...

Very interesting and practical application -- An obstetrics application for use on the iPhone has been cleared by the Food and Drug Administration,  says the company that created it. San Antonio, Texas-based AirStrip Technologies, which...

Funny post on "the wonder of electronics" over at Dr. Wes. Wes tells me the entire story is true. Some other great posts as well from the past week worth checking...

Two more blogging pathologists - welcome to the blogosphere! Both have been linked on the blog roll on the right. The 1x Objective Karl Robstad, MD is a PGY-2 pathology resident at Albany Medical Center in Albany, NY.  He...

OR

platinum partners

gold partners

Silver Partners

Media Partners